泰国批准紧急使用科兴新冠疫苗
泰国食品和药品监督管理局(FDA)授予科兴(SVA.US)新冠疫苗的紧急使用授权,泰国即将在数日内收到200万剂疫苗中的20万剂,会首先为医护人员接种。
管理局副局长Surachok Tangwiwat表示,紧急使用授权从2月22日起生效,有效期为一年。
此前泰国已从阿斯利康(AZN.US)订购2,600万剂疫苗,并且再预订多3,500万剂。现年66岁的泰国总理巴育表示,已准备好接种科兴疫苗,但当地卫生部门只批准60岁以下人士接种。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.